These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 3234484)

  • 1. Inhibition of enkephalin degradation by phelorphan: effects on striatal [Met5]enkephalin levels and jump latency in mouse hot plate test.
    Van Amsterdam JG; Llorens-Cortes C
    Eur J Pharmacol; 1988 Sep; 154(3):319-24. PubMed ID: 3234484
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nociception, enkephalin content and dipeptidyl carboxypeptidase activity in brain of mice treated with exopeptidase inhibitors.
    Zhang AZ; Yang HY; Costa E
    Neuropharmacology; 1982 Jul; 21(7):625-30. PubMed ID: 6750433
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo effects of kelatorphan on enkephalin metabolism in rodent brain.
    Waksman G; Bouboutou R; Devin J; Bourgoin S; Cesselin F; Hamon M; Fournie-Zaluski MC; Roques B
    Eur J Pharmacol; 1985 Nov; 117(2):233-43. PubMed ID: 3865779
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibitors of an enkephalin degrading membrane-bound metalloendopeptidase: analgesic properties and effects on striatal enkephalin levels.
    Murthy LR; Glick SD; Almenoff J; Wilk S; Orlowski M
    Eur J Pharmacol; 1984 Jul; 102(2):305-13. PubMed ID: 6383843
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Composite effects of actinonin when inhibiting enkephalin-degrading enzymes.
    Hachisu M; Hiranuma T; Shibazaki Y; Uotani K; Murata S; Aoyagi T; Umezawa H
    Eur J Pharmacol; 1987 May; 137(1):59-65. PubMed ID: 2886348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of enkephalin degradation attenuated stress-induced motor suppression (conditioned suppression of motility).
    Nabeshima T; Katoh A; Kameyama T
    J Pharmacol Exp Ther; 1988 Jan; 244(1):303-9. PubMed ID: 3422094
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of peptidase inhibitors on the [Met5]-enkephalin hydrolysis in ileal and striatal preparations of guinea-pig: almost complete protection of degradation by the combination of amastatin, captopril and thiorphan.
    Hiranuma T; Oka T
    Jpn J Pharmacol; 1986 Aug; 41(4):437-46. PubMed ID: 3534399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effects of D-phenylalanine and its derivatives on enkephalin degradation in vitro: relation to analgesia and attenuation of the morphine withdrawal syndrome.
    Janicki PK; Gumułka SW; Szreniawski Z; Paulo EA; Arnold Z
    Pol J Pharmacol Pharm; 1986; 38(1):41-9. PubMed ID: 3763485
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of thiorphan on the antinociceptive actions of intrathecal [D-Ala2,Met5] enkephalin.
    Yaksh TL; Harty GJ
    Eur J Pharmacol; 1982 Apr; 79(3-4):293-300. PubMed ID: 7047177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analgesic effects of kelatorphan, a new highly potent inhibitor of multiple enkephalin degrading enzymes.
    Fournie-Zaluski MC; Chaillet P; Bouboutou R; Coulaud A; Cherot P; Waksman G; Costentin J; Roques BP
    Eur J Pharmacol; 1984 Jul; 102(3-4):525-8. PubMed ID: 6386492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enzymatic inactivation of enkephalin neurotransmitters in the spinal cord of the neonatal rat.
    Suzuki H; Yanagisawa M; Yoshioka K; Hosoki R; Otsuka M
    Neurosci Res; 1997 Jul; 28(3):261-7. PubMed ID: 9237274
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of delta opioid receptors in the effects of inhibitors of enkephalin-degrading peptidases on the horizontal and vertical components of locomotion in mice.
    Michael-Titus A; Dourmap N; Costentin J; Schwartz JC
    Neuropeptides; 1990 Feb; 15(2):89-100. PubMed ID: 1981928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiorphan potentiation of stress-induced analgesia in the mouse.
    Greenberg R; O'Keefe EH
    Life Sci; 1982 Sep 20-27; 31(12-13):1185-8. PubMed ID: 6755120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Enkephalin-degrading dipeptidylaminopeptidase: characterization of the active site and selective inhibition.
    Chérot P; Devin J; Fournié-Zaluski MC; Roques BP
    Mol Pharmacol; 1986 Oct; 30(4):338-44. PubMed ID: 3531805
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Possible role of dipeptidyl carboxypeptidase n the metabolism of Met5-enkephalin and Met5-enkephalin-Arg6-Phe7.
    Yang HY; Harsing LG; Majane EM; Costa E
    Adv Biochem Psychopharmacol; 1982; 33():251-60. PubMed ID: 6751032
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of inhibitors of enkephalin degradation in the isolated guinea-pig ileum.
    van Amsterdam JG; van Buuren KJ; Krielaart MJ; Zuiderveld OP; Tijms RP
    Life Sci; 1988; 43(19):1529-36. PubMed ID: 3193845
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hypoalgesic action of bestatin analogues that inhibit central aminopeptidases, but not neutral endopeptidase.
    Otero MJ; Iglesias T; Fuentes JA
    Neuropeptides; 1993 Sep; 25(3):175-82. PubMed ID: 8247255
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Studies on the effect of SCH-34826 and thiorphan on [Met5]enkephalin levels and release in rat spinal cord.
    Yaksh TL; Chipkin RE
    Eur J Pharmacol; 1989 Aug; 167(3):367-73. PubMed ID: 2806377
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New carboxyalkyl inhibitors of brain enkephalinase: synthesis, biological activity, and analgesic properties.
    Fournié-Zaluski MC; Chaillet P; Soroca-Lucas E; Marçais-Collado H; Costentin J; Roques BP
    J Med Chem; 1983 Jan; 26(1):60-5. PubMed ID: 6298420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of bestatin and thiorphan on [Met5]enkephalin-Arg6-Phe7-induced analgesia.
    Reggiani A; Carenzi A; Frigeni V; Della Bella D
    Eur J Pharmacol; 1984 Oct; 105(3-4):361-4. PubMed ID: 6391939
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.